SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 23.72
(0.08%)
EUR 23.72
(0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | 181.65 Million | 182.12 Million | 132.21 Million | 104.39 Million |
| Net Income | 151.93 Million | 125.84 Million | 101.16 Million | 77.62 Million |
| Depreciation & Amortization | 51.84 Million | 55.35 Million | 36.44 Million | 33.72 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -13.7 Million | 1.6 Million | 744 Thousand | 810 Thousand |
| Other non-cash items | -8.42 Million | -682 Thousand | -6.14 Million | -7.76 Million |
| Investing Cash Flow | -171.41 Million | -142.13 Million | -95.89 Million | -81.21 Million |
| Investments in PPE | -175.52 Million | -152.68 Million | -98.62 Million | -85.31 Million |
| Acquisitions | 4.77 Million | 12.35 Million | 1.2 Million | 2.84 Million |
| Investment purchases | -663 Thousand | -1.8 Million | -1.34 Million | - |
| Sales/Maturities of investments | -4.77 Million | -12.35 Million | -1.2 Million | - |
| Other Investing Activities | 4.77 Million | 12.35 Million | 4.08 Million | 1.25 Million |
| Financing Cash Flow | -11.39 Million | -42.38 Million | -27.5 Million | -14.44 Million |
| Debt repayment | -15 Thousand | -18 Thousand | -606 Thousand | -650 Thousand |
| Dividends payments | -18.87 Million | -11.45 Million | -39.82 Million | -44.04 Million |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other Financing Activities | 7.49 Million | -30.9 Million | 12.92 Million | 30.24 Million |
| Accounts receivables | -32.43 Million | -35.57 Million | -18.49 Million | -19.67 Million |
| Accounts payables | -3.9 Million | 29.11 Million | 873 Thousand | 14.35 Million |
| Inventory | -15.38 Million | -30.63 Million | -19.05 Million | -12.12 Million |
| Other working capital | 38.01 Million | 38.69 Million | 37.42 Million | 18.24 Million |
| Cash at beginning of period | 28.79 Million | 27.85 Million | 18.6 Million | 15.65 Million |
| Cash at end of period | 24.35 Million | 28.79 Million | 27.85 Million | 18.6 Million |
| Capital Expenditure | -175.52 Million | -152.68 Million | -98.62 Million | -85.31 Million |
| Effect of forex changes on cash | -3.28 Million | 3.33 Million | 437 Thousand | -5.78 Million |
| Net cash flow / Change in cash | -4.43 Million | 936 Thousand | 9.25 Million | 2.94 Million |
| Free Cash Flow | 6.12 Million | 29.43 Million | 33.58 Million | 19.08 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.43 Million | 25.19 Million | 45 Million | 151.93 Million | 34.7 Million | 30.55 Million |
| Depreciation & Amortization | 16.5 Million | 15.83 Million | 14.63 Million | 51.84 Million | 19.05 Million | 13.39 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.3 Million | -20.88 Million | 26.72 Million | -13.7 Million | -7.07 Million | -186 Thousand |
| Other non-cash items | -3.46 Million | 5.59 Million | -20.35 Million | -8.42 Million | -3.05 Million | -1.35 Million |
| Investing Cash Flow | -24.21 Million | -28.57 Million | -28.6 Million | -171.41 Million | -87.11 Million | -30.63 Million |
| Investments in PPE | -23.89 Million | -28.24 Million | -28.47 Million | -175.52 Million | -88.86 Million | -32.92 Million |
| Acquisitions | 181 Thousand | 223 Thousand | 555 Thousand | 4.77 Million | - | - |
| Investment purchases | -502 Thousand | -560 Thousand | -683 Thousand | -663 Thousand | -135 Thousand | -528 Thousand |
| Sales/Maturities of investments | - | - | - | -4.77 Million | - | - |
| Other Investing Activities | 153 Thousand | - | - | 4.77 Million | 1.88 Million | - |
| Financing Cash Flow | -30.04 Million | 840 Thousand | -39.56 Million | -11.39 Million | 47.47 Million | -9.12 Million |
| Debt repayment | - | - | - | -15 Thousand | -252 Thousand | - |
| Dividends payments | - | -22.59 Million | - | -18.87 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -29.04 Million | 24.15 Million | -39.56 Million | 7.49 Million | 47.47 Million | 10.24 Million |
| Accounts receivables | -39.84 Million | -7.48 Million | 10.92 Million | -32.43 Million | - | - |
| Accounts payables | 17.07 Million | -1.8 Million | -11.63 Million | -3.9 Million | - | - |
| Inventory | -461 Thousand | -7.55 Million | -940 Thousand | -15.38 Million | 4.87 Million | -2.71 Million |
| Other working capital | 16.09 Million | -18.3 Million | 28.37 Million | 38.01 Million | -11.94 Million | - |
| Cash at beginning of period | 19.01 Million | 21.33 Million | 24.35 Million | 28.79 Million | 20.9 Million | 20.91 Million |
| Cash at end of period | 22.15 Million | 19.01 Million | 21.33 Million | 24.35 Million | 24.35 Million | 20.9 Million |
| Capital Expenditure | -23.89 Million | -28.24 Million | -28.47 Million | -175.52 Million | -88.86 Million | -32.92 Million |
| Effect of forex changes on cash | -514 Thousand | -16 Thousand | -859 Thousand | -3.28 Million | -540 Thousand | -219 Thousand |
| Net cash flow / Change in cash | 3.13 Million | -2.32 Million | -3.01 Million | -4.43 Million | 3.45 Million | -19 Thousand |
| Free Cash Flow | 34.02 Million | -2.81 Million | 37.53 Million | 6.12 Million | -45.22 Million | 7.04 Million |
TCBS
NVAAF
VC
PAE
ALC
MAPSW